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Some pro- and anti-inflammatory cytokines and angiogenesis-related factors play im-
portant roles in the inflammatory response after surgery.  To study their kinetics and
mutual relationships after major lung resection for lung cancer, concentrations of
interleukin (IL)-6, -8 and -10 and vascular endothelial growth factor (VEGF) were
measured in serum and pleural fluid.  Venous blood and pleural fluid samples were
collected before and up until 5 days after surgery from 10 patients with lung cancer,
treated by standard lobectomy at Tottori University Hospital between 1997 and 1999.
Cytokine levels after surgery were significantly higher than control levels before surgery
in serum and pleural fluid.  In pleural fluid, cytokines and VEGF increased after surgery
10 to 100 times than in serum.  IL-6 and -10 reached their peaks in pleural fluid later
than in serum, and then gradually decreased.  Serum IL-8 reached its peak at 3 h,
decreased until day 2 and then remained stable.  Serum VEGF decreased until 3 h, and
then showed little change.  Pleural fluid IL-8 and VEGF reached their peaks at 3 or 6 h,
decreased until day 2 and then increased up to day 5.  The amount of cytokines produced
per hour in drainage pleural fluid showed nearly the same kinetics as serum cytokines.
Serum cytokines and VEGF showed higher coefficient values to the hourly production
in pleural fluid than to the pleural fluid levels.  During wound healing, IL-8 acted as a
pro-inflammatory cytokine in the early phase, but as an angiogenic factor like VEGF
in the late proliferative phase.  The cytokine production per hour in pleural fluid is
believed to be a useful marker of cytokine levels for evaluating surgical trauma after
major lung resection for lung cancer.
Key words:  cytokine; cytokine production per hour (hourly production of cytokine); lung cancer;
vascular endothelial growth factor; wound healing
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Interleukin (IL)-6 and IL-8 are known as pro-
inflammatory cytokines, and IL-10 as an anti-
inflammatory cytokine.  There have been many
reports about the kinetics of pro- and anti-
inflammatory cytokine levels after surgery, in-
cluding thoracic procedures (Steinberg et al.,
1993; Sakamoto et al., 1994; Kawahito et al.,
1995; Waller et al., 1996; Atwell et al., 1998;
Liebold et al., 1999; Weissflog et al., 1999).  How-
ever, most reports have described serum levels
of cytokines, and few have reported their pleu-
ral fluid levels (Sakamoto et al., 1994; Weissflog
et al., 1999).  Thus, we thought it would be inter-
esting to investigate the relationship of cytokine
levels between serum and pleural fluid.  In addi-
tion, vascular endothelial growth factor (VEGF)
known as an important angiogenic factor
(Fontanini et al., 1997; Inoue et al., 1997), has
recently been demonstrated as acting together
with pro- and anti-inflammatory cytokines
(Ishimura et al., 1998; Nissen et al., 1998; Sato et
al., 1999).  In the present study, to clarify whe-
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ther IL-6, IL-8, IL-10 and VEGF are associated
after surgery for lung cancer, the kinetics of the
levels of IL-6, IL-8, IL-10 and VEGF in both se-
rum and pleural fluid were investigated.
Materials and Methods
Patients
The subjects were recruited from non-small cell
lung cancer patients who underwent standard
lobectomy by posterolateral thoracotomy with
mediastinal nodal dissection in Tottori Univer-
sity Hospital between October 1997 and June
1999.  We applied the following exclusion cri-
teria for patient selection:  i) incomplete resec-
tion, because the residual tumor has the poten-
tial to affect the cytokine levels (Matsuguchi et
al., 1991; Yamamoto et al., 1996); ii) extended
resection of the chest wall, diaphragm or medi-
astinum, because different degrees of surgical
trauma have the potential to affect the cytokine
levels (Sakamoto et al., 1994); iii) administ-
ration of perioperative ulinastatin or cortico-
steroid, because these agents influence cytokine
release (Teoh et al., 1995; Kawamura et al.,
1996) and iv) complication by pulmonary fibro-
sis, because this condition has the potential to
affect the IL-8 level (Keane et al., 1997).
A total of 10 patients were examined in this
study.  They ranged in age from 49 to 76 years
(mean, 64.3 years), consisting of 5 males and 5
females.  Histologically, 3 patients suffered
with squamous cell carcinomas, 6 patients with
adenocarcinomas and 1 patient with mucoepi-
dermoid carcinoma.  Seven patients were in
Stage I, one was in Stage II and two were in
Stage III.  All patients gave written informed
consent.  After tracheal intubation (double
lumen endotracheal tube), general anesthesia
was applied in combination with a thoracic
epidural anesthesia in all patients.  The thoracic
epidural catheter was used for postoperative
analgesia.   Two thoracic tubes were indwelled
in all patients, and the pleural fluid was con-
stantly aspirated with –10 cmH2O pressure.
The duration of the surgery was 304.9 ± 13.3
min and the bleeding volume was 181.3 ± 57.3
mL.  There were no severe postoperative com-
plications such as respiratory failure, pneumo-
nia, liver dysfunction or renal failure in these
patients.
Blood and pleural fluid collection
Samples of venous blood were collected imme-
diately after induction of anesthesia, and served
as controls.  Samples of pleural fluid were col-
lected by intrathoracic lavage with 50 mL of
physiological saline just after thoracotomy, and
used to determine the preoperative control data
of pleural fluid.
The other samples of serum and pleural
fluid were simultaneously collected at 3 and 6 h
and on days 1, 2, 3 and 5 after surgery.  On days
1, 2, 3 and 5, the samples were collected 9:00 in
the morning.  All samples were centrifuged im-
mediately at 2,500 rpm for 15 min at 4˚C.  Cen-
trifuged samples were stored at –30˚C until the
assays were performed.
Cytokine assays
IL-6, IL-8, IL-10 and VEGF concentrations
were measured using commercial enzyme-
linked immunosorbent assay kits (Genzyme,
Cambridge, MA for IL-6 and IL-10; Endogen,
Woburn, MA for IL-8; Techne, Minneapolis,
MN for VEGF).
Statistical analysis
Statistical analysis was performed with Stat-
View 5.0 J software (Abacus, Concepts, Inc.,
Berkeley, CA).  Differences in the kinetics of
cytokine and VEGF levels were analyzed using
Friedman’s test and Wilcoxon’s signed rank
test.  Correlations between the serum and pleu-
ral fluid levels of cytokines and VEGF were
analyzed using Spearman’s test.  Results are ex-
pressed as mean ± SEM.  P values of < 0.05
were considered significant.
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Figs. 1A–D.  Kinetics of serum levels of cyto-
kines and VEGF measured before and after
lung resection.  *P < 0.05 and **P < 0.01
compared with the preoperative control level.
The data are presented as mean ± SEM.  IL,
interleukin; VEGF, vascular endothelial
growth factor.
Results
Kinetics of serum cytokine and
VEGF levels
Serum levels of cytokines after surgery
(Figs. 1A–C) were significantly higher
than control levels throughout.  IL-6 (Fig.
1A) and IL-10 (Fig. 1C) reached their
peaks at 3 h (IL-6:  626.8 ± 63.0 pg/mL,
IL-10:  15.9 ± 1.6 pg/mL) and gradually
declined with time.  Serum IL-8  (Fig.
1B) showed its peak at 3 h (47.5 ± 12.0
pg/mL), declined until day 2 and then re-
mained stable.  However, serum VEGF
levels (Fig. 1D) decreased until 3 h, fol-
lowed by little change.
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Figs. 2A–D.  Kinetics of pleural fluid levels
of cytokines and VEGF measured before
and after lung resection.  *P < 0.05 and **P
< 0.01 compared with the preoperative con-
trol level.  The data are presented as mean ±
SEM.  IL, interleukin; VEGF, vascular
endothelial growth factor.
Kinetics of drainage fluid cyto-
kine and VEGF levels
Pleural fluid levels of cytokines and
VEGF (Figs. 2A–D) after surgery were
significantly higher than control levels
throughout.  IL-6 and IL-8 were about
100-fold and IL-10 and VEGF were
about 10-fold higher in concentration
than in serum.  Concerning level changes,
IL-6 (Fig. 2A) and IL-10 (Fig. 2C) reach-
ed their peaks (IL-6:  177,000 ± 30,600
pg/mL, IL-10:  481.0 ± 91.8 pg/mL) 6 h
or 1 day after surgery, later than in the
patterns seen in serum.  In pleural fluid,
however, IL-8 (Fig. 2B) and VEGF
(Fig. 2D) levels showed their peaks in
the early phases, at 3 or 6 h (IL-8:
19,700 ± 5030 pg/mL, VEGF: 1838 ±
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Figs. 3A–D.  Kinetics of hourly production
in pleural fluid of cytokines and VEGF
measured before and after lung resection.
*P < 0.05 and **P < 0.01 compared with
the preoperative control level.  The data are
presented as mean ± SEM.  IL, interleukin;
VEGF, vascular endothelial growth factor.
182 pg/mL), decreased until day 2 (IL-
8:  2286 ± 787 pg/mL, VEGF:  980 ±
223 pg/mL) and elevated again during
the late phase up to day 5 (IL-8:  14,900
± 9580 pg/mL, VEGF:  1553 ± 261 pg/
mL).  When the amount of cytokines
produced per hour (hourly production)
in pleural fluid was calculated by mul-
tiplying the concentration by drainage
volume per hour, the hourly cytokine
production in pleural fluid (Figs. 3A–
C) showed nearly the same kinetics as
serum concentration kinetics (Figs.
1A–C).
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Relationships of cytokine and
VEGF levels between serum
and pleural fluid
All factors showed significant cor-
relations between serum levels and
hourly productions in pleural fluid
(IL-6:  r = 0.777, IL-8:  r = 0.550,
IL-10:  r = 0.580, VEGF:  r = 0.264)
(Figs. 4A–D).  These values of co-
efficients were higher than those
between serum levels and pleural
fluid levels for all factors (IL-6:  r =
0.517, IL-8:  r = 0.494, IL-10:  r =
0.564, VEGF:  r = 0.235).
Discussion
Various cytokines with a wide
range of biological activities play
the role of controlling inflammatory
and immunological reactions to sur-
gical trauma.  In the present study,
the concentrations of cytokines in
pleural fluid were about 100-fold
greater than those in serum.  Pre-
vious researchers also reported that
the IL-6 and IL-8 levels in thoracic
drainage fluid were about 100- to
1000-fold greater than those in pe-
ripheral blood (Sakamoto et al.,
1994; Krohn et al., 1998).  There-
fore, it is very clear that the cytokine
response is much stronger in the lo-
cal pleural cavity than in the sys-
temic blood.
Figs. 4A–D.  Relationships between
serum levels and hourly productions in
pleural fluid studied for cytokines and
VEGF.  IL, interleukin; VEGF, vascular
endothelial growth factor.
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In our present study, the kinetics of cytokine
levels in serum and pleural fluid showed sig-
nificant correlations.  In particular, the correla-
tion between the hourly cytokine production in
pleural fluid and the serum cytokine level was
higher than that between the pleural fluid
cytokine level and the serum cytokine level.
Sakamoto et al. (1994) reported that the mes-
senger RNAs of cytokines could not be detected
in leukocytes from the peripheral blood but
could be demonstrated in leukocytes from
drainage fluid:  they suggested that cytokines
are induced and secreted mainly in the surgical
field and simultaneously appear in the blood
stream.  Asadullah et al. (1995) reported data
from neurosurgery supporting this hypothesis.
Regarding the mechanism of this effect, we
consider it possible that pleural cytokines spill
over into the peripheral blood through pleural
absorption.  Therefore, when the concentrations
of cytokines in pleural fluid are markedly high-
er than serum cytokine levels, such as after tho-
racic surgery, serum cytokine levels are strong-
ly influenced by the amount of cytokines pro-
duced per hour in pleural fluid.  Pleural fluid
can be collected because the thoracic tube is al-
ways indwelled after thoracic surgery.  Thus,
the hourly production of cytokines in pleural
fluid appears to be a new useful marker of cyto-
kine levels for evaluating the degree of trauma
caused by thoracic procedures.
IL-8 is a pro-inflammatory cytokine and has
a potent chemoattractant activity for neutro-
phils (Baggiolini et al., 1989).  Recent studies
have shown that the serum IL-8 level peaked
within 24 h after surgery and decreased there-
after (Sakamoto et al., 1994; Atwell et al., 1998;
Liebold et al., 1999).  However, few studies
have examined the kinetics of IL-8 later than 3
days after surgery, particularly after major lung
surgery.  In the present study, the kinetics of the
IL-8 level in pleural fluid showed 2 significant
peaks postoperatively, at 3 or 6 h and again on
day 5.  Until day 2 after surgery, IL-8 func-
tioned as a pro-inflammatory cytokine.  How-
ever, re-elevation of IL-8 later than day 3 did
not necessarily indicate its function as a pro-
inflammatory cytokine at that time.  Koch et al.
(1992) reported that IL-8 has another function;
it induces neovascularization without inflam-
mation.  During wound healing, the period until
day 3 after surgery corresponds to an inflamma-
tory phase, while the period later than day 3
corresponds to a proliferative phase (Fine and
Mustoe, 1997) during which angiogenesis occurs
at the wound site (Adzick, 1997).  Grad et al.
(1998) reported that, in multiple trauma pa-
tients, serum VEGF was elevated from day 3
after injury.  Angiogenesis-related factors such
as VEGF are induced in hypoxia (Shweiki et al.,
1992; Steinbrech et al., 1999).  Hangai (1996)
reported that the tissue oxygen tension at the
anastomosis site reached its lowest level on day
3 after tracheoplasty.  Therefore, this condition
may re-elevate VEGF levels after day 3.  Be-
cause both IL-8 and VEGF showed the same ki-
netics in pleural fluid, we figured that the func-
tion of IL-8 later than day 3 after surgery could
act as an angiogenic factor rather than as a pro-
inflammatory cytokine.
In the present study, IL-8 and VEGF were
produced at high levels in pleural fluid after
lung surgery.  Angiogenesis is required for the
growth and metastasis of solid tumors (Folkman
et al., 1989; Bicknell and Harris, 1991; Imoto et
al., 1998), and anti-IL-8 and anti-VEGF therapy
can inhibit both primary tumor growth and
metastasis (Asano et al., 1995; Warren et al.,
1995; Arenberg et al., 1996; Rowe et al., 2000).
Moreover, the inflammatory cytokine level in
serum was reported to be higher after lobecto-
my of the lung than by gastrectomy and colo-
rectal resection (Sakamoto et al., 1994).   Pro-
inflammatory cytokines such as IL-6 and IL-8
stimulate VEGF expression (Hanahan and
Folkman, 1996; Risau, 1997).  It has been re-
ported that excess surgical stress from thoraco-
tomy facilitates metastasis (Hattori et al., 1980;
Hirai et al., 1997).  Furthermore, Gabrilovich et
al. (1996) recently reported that in vivo VEGF
can inhibit the functional maturation of dendrit-
ic cells which play a critical role in antitumor
immune responses.  Based on the above, lobec-
tomy by standard thoracotomy for lung cancer
may likely induce proliferation and metastasis
of the tumor not only due to angiogenesis but
also to tumor immunity because VEGF was
produced at high levels after lung resection.
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Our study examined only a small number of
patients who underwent elective surgery for
lung cancer.  Also, because none of our patients
had severe postoperative complications, our
findings only reflected normal cytokine kinetics
after major lung resection for lung cancer.
Therefore, further studies are needed to investi-
gate whether our findings are applicable to
wedge resection, to lobectomy under video-
assisted thoracic surgery regarded as minimally
invasive for lung cancer, to extended proce-
dures such as pneumonectomy and combined
resection of other involved organs for primary
lung cancer, and to lung surgery for conditions
other than malignancy.  If the cytokine cascade
producing the pro- and anti-inflammatory and
angiogenic reactions were balanced, normal
healing after surgical trauma could be achieved.
However, overexpression of angiogenic factors
such as IL-8 and VEGF might promote recur-
rence or metastasis of cancer cells.  Therefore,
studies of cytokine kinetics will facilitate un-
derstanding of the normal biological response
and provide reference information for optimal
perioperative patient management.
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